The clinical benefits of sodium-glucose cotransporter type 2 inhibitors in people with gout
Related Posts
Gunsalus RP, Humm E, Cook L, Wofford NQ, James KL, Pellegrini M, Morselli M, Ha SM, McInerney MJ. Whole genome sequence of the syntrophic benzoate-degrading[...]
Ahmad E, Ahmad S, Naeem A, Ahmed S, Shehzad M, Akram U, Ashraf H, Rehman OU, Ullah I, Ahmed R, Alraies C, Fonarow GC. Trends[...]
Asada H, Takami M, Mori S, Izawa Y, Kawamori H, Fukuzawa K. Right Coronary Artery Occlusion due to Adventitial Hematoma During Cavotricuspid Isthmus Ablation. JACC[...]